Equillium, Inc. Files 8-K: Other Events
Ticker: EQ · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1746466
| Field | Detail |
|---|---|
| Company | Equillium, INC. (EQ) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-events
Related Tickers: EQUL
TL;DR
Equillium filed an 8-K for 'Other Events' on Feb 6. Details TBD.
AI Summary
Equillium, Inc. filed an 8-K on February 6, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or other named entities beyond the company itself.
Why It Matters
This filing indicates a material event has occurred for Equillium, Inc., but the lack of detail requires further investigation to understand its implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, creating uncertainty about potential impacts.
Key Players & Entities
- Equillium, Inc. (company) — Registrant
- February 6, 2025 (date) — Filing Date
FAQ
What specific event(s) are being reported under 'Other Events'?
The filing does not specify the nature of the 'Other Events'.
When was this 8-K filing submitted?
The filing was submitted on February 6, 2025.
What is the principal executive office address for Equillium, Inc.?
The address is 2223 Avenida de la Playa, Suite 105, La Jolla, California, 92037.
What is Equillium, Inc.'s telephone number?
The telephone number is (858) 240-1200.
What is the SIC code for Equillium, Inc.?
The Standard Industrial Classification code is 2834 (Pharmaceutical Preparations).
Filing Stats: 1,071 words · 4 min read · ~4 pages · Grade level 13.5 · Accepted 2025-02-06 08:01:27
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share EQ Nasdaq Capital Market
Filing Documents
- d898732d8k.htm (8-K) — 32KB
- g898732dsp004.jpg (GRAPHIC) — 53KB
- 0001193125-25-021348.txt ( ) — 287KB
- eq-20250206.xsd (EX-101.SCH) — 3KB
- eq-20250206_lab.xml (EX-101.LAB) — 18KB
- eq-20250206_pre.xml (EX-101.PRE) — 11KB
- d898732d8k_htm.xml (XML) — 4KB
Forward-Looking Statements
Forward-Looking Statements
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Equillium, Inc. Dated: February 6, 2025 By: /s/ Jason A. Keyes Jason A. Keyes Chief Financial Officer